Sylver Quevedo, MD, MPH is an Associate Professor of Medicine at the University of California, San Francisco. He is a principal investigator in the MAPS-sponsored FDA trial of MDMA-assisted therapy for PTSD. He graduated with honors in biology from the University of California, Berkeley and earned his medical degree at the Harvard Medical School and the Master of Public Health degree at Harvard School of Public Health. Dr. Quevedo has served on national boards and committees of the American Kidney Fund, the Institute of Medicine of the National Academy of Sciences, and the American College of Physicians. He is Chairman of the Board of the Trust for Indigenous
Culture and Health of Nairobi, Kenya and New York, NY.